Evidence for Clonally Associated Increasing Rates of Azithromycin Resistant Neisseria gonorrhoeae in Rio de Janeiro, Brazil

Azithromycin is one of the drugs used in the combined therapy for syndromic treatment of gonorrhoea in many countries, including Brazil. Our research group, which receives isolates from clinical laboratories since 2006, has detected, after 2016, a tendency of rising rates of azithromycin resistance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros dos Santos, Késia T., Skaf, Larissa B., Justo-da-Silva, Livia H., Medeiros, Raphael C., Francisco Junior, Ronaldo da S., Caniné, Maria Cristina A., Fracalanzza, Sergio E. L., Bonelli, Raquel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360546/
https://www.ncbi.nlm.nih.gov/pubmed/30800666
http://dx.doi.org/10.1155/2019/3180580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360546/
https://www.ncbi.nlm.nih.gov/pubmed/30800666
http://dx.doi.org/10.1155/2019/3180580

Ejemplares similares